Marina Yamashita
Overview
Explore the profile of Marina Yamashita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
52
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sega M, Yamashita M, Maruyama H, Taya Y, Ohgi K, Haraoka R, et al.
Medicina (Kaunas)
. 2024 May;
60(5).
PMID: 38792877
Renal embolisms due to cardiac myxomas are extremely rare; the clinical course, treatment, and prognosis of this disease are not established. A 69-year-old Japanese woman who underwent a nephrectomy for...
2.
Shimohata H, Usui J, Tawara-Iida T, Ebihara I, Ishizu T, Maeda Y, et al.
Clin Exp Nephrol
. 2024 Jan;
28(5):457-464.
PMID: 38238500
Background: Patients with end-stage kidney disease (ESKD) are at high risk of cardiovascular disease including stroke, heart failure, and ischemic heart disease (IHD). To prevent the occurrence and progression of...
3.
Yamashita M, Takayasu M, Maruyama H, Hirayama K
Medicina (Kaunas)
. 2023 Nov;
59(11).
PMID: 38004064
Combination therapy with glucocorticoids, cyclophosphamide, and plasmapheresis is recommended as the standard treatment for anti-glomerular basement membrane (anti-GBM) disease, but the prognosis of this disease remains poor. Several immunobiological agents...
4.
Shimohata H, Yamashita M, Yamada K, Hirayama K, Kobayashi M
Medicina (Kaunas)
. 2023 Aug;
59(8).
PMID: 37629768
Fabry disease is an X-linked inherited lysosomal storage disorder with a deficiency of α-galactosidase A activity, which results in the intracellular accumulation of globotriaosylceramide (Gb3) and related glycosphingolipids in various...
5.
Shimohata H, Iwaki Y, Yamashita M, Ohgi K, Maruyama H, Takayasu M, et al.
Int Urol Nephrol
. 2021 Nov;
54(8):1907-1914.
PMID: 34843041
Purpose: The sodium-glucose cotransporter 2 (SGLT2) inhibitors comprise a new class of glucose-lowering drugs for individuals with diabetes. Large-scale clinical trials indicated that SGLT2 inhibitors have both a cardiovascular-protective and...
6.
Rosadas C, Assone T, Yamashita M, Adonis A, Puccioni-Sohler M, Santos M, et al.
PLoS Negl Trop Dis
. 2020 Oct;
14(10):e0008761.
PMID: 33064742
Background: HTLV-1 is a neglected sexually transmitted infection despite being the cause of disabling neurological disease HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). There is no treatment for this infection and public...
7.
Maruyama H, Hirayama K, Yamashita M, Ohgi K, Tsujimoto R, Takayasu M, et al.
BMC Rheumatol
. 2020 Sep;
4:36.
PMID: 32864569
Background: Proteasomes are found in both the cell nucleus and cytoplasm and play a major role in the ubiquitin-dependent and -independent non-lysosomal pathways of intracellular protein degradation. Proteasomes are also...
8.
Shimohata H, Imagawa K, Yamashita M, Ohgi K, Maruyama H, Takayasu M, et al.
Intern Med
. 2020 Jul;
59(22):2907-2910.
PMID: 32727995
Alagille syndrome is an inherited multisystemic disorder. We herein report an atypical case of a Japanese adult patient with Alagille syndrome. He had been diagnosed with Alagille syndrome as an...
9.
Shimohata H, Yamashita M, Ohgi K, Maruyama H, Takayasu M, Hirayama K, et al.
CEN Case Rep
. 2020 Mar;
9(3):237-242.
PMID: 32189245
Fabry disease is an X-linked inherited lysosomal storage disorder caused by a deficiency of α-galactosidase A activity, resulting in the intracellular accumulation of globotriaosylceramide and related glycosphingolipids. The phenotypes of...
10.
Shimohata H, Yamashita M, Ohgi K, Tsujimoto R, Maruyama H, Takayasu M, et al.
Hemodial Int
. 2019 May;
23(3):369-374.
PMID: 31037843
Introduction Recently, although there are many reports showing that serum magnesium concentration is a predictor of mortality in dialysis patients, the observation periods of those reports were of short duration,...